Free resource · For PAs and primary care
Sleep apnea is now a treatable metabolic disease
Two pages on what changed in OSA management, and what to do with the patient in front of you on Monday. Written for PAs and primary care.
- Who to test even without snoring, and why STOP-BANG is a rule-out tool
- SURMOUNT-OSA in one table: AHI, remission, weight and blood pressure, with and without PAP
- The tirzepatide indication precisely, including the real maintenance doses and why it does not replace PAP
- Two doors to approval: why a BMI of 28 with documented OSA still qualifies
- A prior-auth checklist: what needs to be in the chart before you submit
Doug Maready, MD
Board-certified in Internal Medicine and Obesity Medicine · President, Arizona Obesity Organization
Every number is sourced
Trial names, journals and years on the page, so you can check a figure before you chart it.
Built for the exam room
Screening, the label criteria, and the prior-auth details that decide whether a patient gets treated.
Honest about the gaps
What is FDA-approved, what is hypothesis-generating, and where the evidence stops.
Dr. Maready is a paid speaker for Eli Lilly and Company and Novo Nordisk. This brief is independent educational content, separate from any CME activity, was not funded or reviewed by any manufacturer, and discusses products from multiple companies. For licensed clinicians; it does not replace prescribing information or clinical judgment.